Zimmer Biomet Holdings, Inc. vs Johnson & Johnson
ZBH vs JNJ — side-by-side comparison from reported financials. ZBH leads 5, JNJ leads 6 of 11 comparable metrics.
Zimmer Biomet Holdings, Inc.
ZBH · Healthcare
$89.00+0.14%Mixed
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | ZBH | JNJ |
|---|---|---|
| Price | $89.00 | $261.79 |
| Market cap | $17.0B | $631B |
| Revenue (TTM) | $8.51B | $97.9B |
| Revenue growth | +5.8% | +5.6% |
| Net margin | 9.5% | 21.5% |
| Free cash flow | $1.52B | $22.2B |
| Net cash (debt) | ($6.34B) | ($27.8B) |
| 1-year price return | -8.6% | +37.0% |
| P/E | 21.5 | 29.9 |
| P/E vs own history (cheap-side %) | 96% | 16% |
| Dividend yield | 1.09% | 2.00% |
| Return on equity | 6% | 26% |
| Altman Z-score | 2.15 | — |
| CV checks passed | 11 of 11 | 10 of 11 |
| Employees | 17,000 | 140,800 |
Full résumé-style profiles: ZBH CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.